3 hours Lock In A Phenomenal Yield With Pfizer Seeking Alpha Lock In A Phenomenal Yield With Pfizer. Pfizer (PFE)
8 hours Zacks.com featured highlights include GIII Apparel Group, Sonoco Products, Hamilton Insurance Group, Pampa Energia S.A. and PfizerZacks
10 hours Northwestern Mutual Wealth Management Co. Sells 39,053 Shares of Pfizer Inc. (NYSE:PFE)MarketBeat
23 hours Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner saysInvesting.com
1 day Pfizer Inc. (PFE) Acquires Seagen for $43 Billion, Strengthening Oncology LeadershipInsider Monkey
5 days Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.Investor's Business Daily
1 week Pfizer Inc. (NYSE:PFE) to Post Q3 2025 Earnings of $0.72 Per Share, Zacks Research ForecastsMarketBeat
1 week Pfizer Inc. (PFE): Strong Q2 2024 Dividend Focus with $5 Billion Returned to ShareholdersInsider Monkey
2 weeks 3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold ForeverThe Motley Fool
2 weeks Pfizer says drug for deadly cancer condition that causes weight loss shows positive trial dataCNBC
3 weeks The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart MonopolyThe Wall Street Journal
4 weeks Pfizer Inc. (PFE) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
4 weeks Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive MarketInvestor's Business Daily
1 month Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short SellersInsider Monkey
1 month Why IBD 50’s Alnylam Just Reversed Its 50% Gain — And BridgeBio SurgedInvestor's Business Daily
1 month Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding StocksThe Motley Fool
1 month FDA approves new updated COVID-19 vaccines to target KP.2 variant. Here’s what to knowFast Company
2 months Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its MarkInvestor's Business Daily
2 months Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectivesMarketWatch
2 months Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It’s Not Pfizer)The Motley Fool
2 months Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illnessMarketWatch
2 months Pfizer Inc. (PFE): Should You Add This GLP-1 and Weight Loss Stock to Your Portfolio Now?Insider Monkey
2 months Pfizer to Buy a GLP-1 Drugmaker? Here’s Why You Shouldn’t Count on That HappeningThe Motley Fool